Professional
Added to YB: 2025-10-31
Pitch date: 2025-09-30
TECH [bullish]
Bio-Techne Corporation
+5.08%
current return
Author Info
No bio for this author
Company Info
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
Market Cap
$9.4B
Pitch Price
$55.42
Price Target
N/A
Dividend
0.53%
EV/EBITDA
26.95
P/E
115.41
EV/Sales
7.85
Sector
Life Sciences Tools and Services
Category
value
Mairs & Power – Balanced Fund Added On Portfolio Holding: Bio-Techne Corporation
TECH added to position: Makes high-quality ingredients for biopharma research/production. Underperformed on uncertainty around funding environment due to federal cuts & weak VC funding for biotech research. Recent weakness created buying opportunity.
Read full article (1 min)